Lung Cancer — Non-Small Cell MCQ — NEET PG Practice Question | NEETPGAI
Lung Cancer — Non-Small Cell
hard
microscope Pathology
A 62-year-old woman with newly diagnosed stage IIIA NSCLC (T3N2M0, adenocarcinoma) is being evaluated for treatment. She has adequate pulmonary function (FEV1 65% predicted) and no significant comorbidities. Molecular testing shows EGFR mutation (exon 19 deletion). What is the most appropriate next step in management?
See the options, answer & explanation
Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.
